Insider · CIK 0001525250
Frederick J. Fritz
Files at IMNN (Imunon, Inc.). First filing -, latest -.
In brief
Frederick J. Fritz files SEC Form 4 as director at IMNN (Imunon, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Frederick J. Fritz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | IMNN Imunon, Inc. | AGrant or award Common Stock | +6,934 | $1.59 | $11k | 21,031 | Aug 4, 2026 |
| May 22, 2026 | IMNN Imunon, Inc. | AGrant or award Common Stock | +10,330 | $2.20 | $23k | 14,097 | May 27, 2026 |
| Jan 2, 2026 | IMNN Imunon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,892 | $0.00 | $0 | 5,892 | Jan 6, 2026 |
| Aug 4, 2025 | IMNN Imunon, Inc. | AGrant or award Common Stock | +3,161 | $9.20 | $29k | 3,946 | Aug 6, 2025 |
| Aug 4, 2025 | IMNN Imunon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +250 | $0.00 | $0 | 250 | Aug 6, 2025 |
| Mar 14, 2025 | IMNN Imunon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,750 | $0.00 | $0 | 3,750 | Mar 18, 2025 |
Questions about Frederick J. Fritz
Answered from the filings on this page, as of the latest one.
Is Frederick J. Fritz buying or selling?
Frederick J. Fritz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Frederick J. Fritz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Frederick J. Fritz has 0.
Where does Frederick J. Fritz file Form 4?
Frederick J. Fritz has filed Form 4 at IMNN (Imunon, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.